A detailed history of Fort Washington Investment Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 527,072 shares of MRK stock, worth $67.1 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
527,072
Previous 530,693 0.68%
Holding current value
$67.1 Million
Previous $70 Million 0.68%
% of portfolio
0.46%
Previous 0.46%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $410,042 - $477,790
-3,621 Reduced 0.68%
527,072 $69.5 Million
Q4 2023

Jan 17, 2024

SELL
$100.18 - $109.02 $3.17 Million - $3.45 Million
-31,629 Reduced 5.62%
530,693 $57.9 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $1.09 Million - $1.21 Million
10,627 Added 1.93%
562,322 $57.9 Million
Q2 2023

Jul 28, 2023

SELL
$108.61 - $118.38 $15.5 Million - $16.9 Million
-143,065 Reduced 20.59%
551,695 $63.7 Million
Q1 2023

Apr 28, 2023

SELL
$102.94 - $114.86 $10.6 Million - $11.8 Million
-102,701 Reduced 12.88%
694,760 $73.9 Million
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $3.55 Million - $4.55 Million
-40,545 Reduced 4.84%
797,461 $88.5 Million
Q3 2022

Oct 26, 2022

BUY
$84.53 - $94.96 $1.22 Million - $1.37 Million
14,458 Added 1.76%
838,006 $72.2 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $7.91 Million - $8.97 Million
-94,741 Reduced 10.32%
823,548 $75.1 Million
Q1 2022

May 03, 2022

BUY
$73.51 - $82.4 $912,112 - $1.02 Million
12,408 Added 1.37%
918,289 $75.3 Million
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $11 Million - $13.8 Million
152,749 Added 20.28%
905,881 $69.4 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $33.2 Million - $36.6 Million
463,681 Added 160.19%
753,132 $56.6 Million
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $166,142 - $183,770
-2,363 Reduced 0.81%
289,451 $22.5 Million
Q1 2021

May 05, 2021

SELL
$68.86 - $81.11 $3.39 Million - $4 Million
-49,257 Reduced 14.44%
291,814 $22.5 Million
Q4 2020

Feb 03, 2021

BUY
$71.77 - $79.65 $307,319 - $341,061
4,282 Added 1.27%
341,071 $27.9 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $3.34 Million - $3.79 Million
-45,658 Reduced 11.94%
336,789 $27.9 Million
Q2 2020

Jul 31, 2020

BUY
$70.42 - $80.13 $1.59 Million - $1.81 Million
22,583 Added 6.28%
382,447 $29.6 Million
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $5.83 Million - $8.09 Million
-92,070 Reduced 20.37%
359,864 $27.7 Million
Q4 2019

Feb 03, 2020

SELL
$77.58 - $87.54 $1.72 Million - $1.94 Million
-22,173 Reduced 4.68%
451,934 $41.1 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $3.15 Million - $3.44 Million
-41,421 Reduced 8.03%
474,107 $39.9 Million
Q2 2019

Aug 12, 2019

SELL
$69.84 - $81.59 $4.94 Million - $5.78 Million
-70,791 Reduced 12.07%
515,528 $43.2 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $7.76 Million - $8.85 Million
-111,539 Reduced 15.98%
586,319 $48.8 Million
Q4 2018

Feb 05, 2019

SELL
$65.24 - $75.71 $2.31 Million - $2.68 Million
-35,401 Reduced 4.83%
697,858 $53.3 Million
Q3 2018

Nov 07, 2018

SELL
$57.69 - $67.84 $31,556 - $37,108
-547 Reduced 0.07%
733,259 $52 Million
Q2 2018

Jul 27, 2018

SELL
$50.83 - $59.72 $45,696 - $53,688
-899 Reduced 0.12%
733,806 $44.5 Million
Q1 2018

May 02, 2018

SELL
$50.96 - $59.23 $1.12 Million - $1.3 Million
-21,905 Reduced 2.9%
734,705 $40 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $31.1 Million - $37.1 Million
601,651 Added 388.26%
756,610 $42.6 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $589,633 - $634,456
10,050 Added 6.94%
154,959 $9.92 Million
Q2 2017

Aug 10, 2017

BUY
N/A
144,909
144,909 $9.29 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $322B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.